Status:

UNKNOWN

Does Tranexamic Acid Improve Visualization During Arthroscopic Rotator Cuff Repair

Lead Sponsor:

University of Saskatchewan

Conditions:

Rotator Cuff Tears

Rotator Cuff Injuries

Eligibility:

All Genders

18-100 years

Phase:

PHASE3

Brief Summary

This clinical trial examines whether intravenous preoperative administration of tranexamic acid (TXA) before arthroscopic rotator cuff repair (ARCR) can improve arthroscopic visualization during the p...

Eligibility Criteria

Inclusion

  • Age 18-100
  • Male and Female
  • Patient able to read and understand consent form
  • Non-traumatic, simple small or medium sized rotator cuff tear as defined by pre-operative MRI
  • Booked to operating room for elective rotator cuff repair
  • Beach chair positioning

Exclusion

  • Patient refusal to participate
  • Massive rotator cuff tear
  • Acute traumatic rotator cuff tear
  • Known coagulopathy
  • Patients with a history or risk of thromboembolism
  • Known hypersensitivity to tranexamic acid
  • Patient unable to be off anti-coagulant medication for long enough to counter effects
  • Patient has a clinic systolic blood pressure \> 150mmHg
  • Lateral positioning
  • Requirement or insistence by patient or anesthesiologist on regional block
  • Patients who have smoked nicotine products within the last year
  • The presence of other inflammatory conditions (calcific tendonitis, rheumatoid arthritis, etc.)
  • The presence of active thromboembolic disease, such as deep vein thrombosis, pulmonary embolism, and cerebral thrombosis
  • Patient has a seizure disorder
  • Patients on medications identified as having drug-drug interactions (hormonal contraceptive, hydrochlorothiazide, desmopressin, sulbactam-ampicilllin, carbazochrome, ranitidine, or nitroglycerine
  • Patient is pregnant
  • Patients with history of subarachnoid hemorrhage
  • Patients with renal insufficiency
  • Patients with acquired disturbances of color vision

Key Trial Info

Start Date :

January 13 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2022

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04865380

Start Date

January 13 2021

End Date

April 1 2022

Last Update

May 3 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dash & Reed Sports Medicine

White City, Saskatchewan, Canada, S4L 5B1